Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kroeger Christopher A.
Chief Executive Officer at MapLight Therapeutics. Filing since 15 Apr 2026.
CIK 0001658918
Company
Date
Role
Action
Shares
Amount
Of holding
MPLT
MapLight Therapeutics, Inc.
17 Jul 2026
Chief Executive Officer
Sold at will
16,779
$635.92K
1.3%
MPLT
MapLight Therapeutics, Inc.
16 Jul 2026
Chief Executive Officer
Sold at will
69,082
$2.54M
5.2%
MPLT
MapLight Therapeutics, Inc.
15 Jul 2026
Chief Executive Officer
Sold at will
61,778
$2.27M
4.4%
MPLT
MapLight Therapeutics, Inc.
18 May 2026
Chief Executive Officer
Sold on a plan
118,235
$3.21M
7.8%
MPLT
MapLight Therapeutics, Inc.
11 May 2026
Chief Executive Officer
Sold on a plan
13,980
$421.00K
0.9%
MPLT
MapLight Therapeutics, Inc.
8 May 2026
Chief Executive Officer
Sold on a plan
34,411
$952.84K
2.2%
MPLT
MapLight Therapeutics, Inc.
7 May 2026
Chief Executive Officer
Sold on a plan
20,100
$575.80K
1.3%
MPLT
MapLight Therapeutics, Inc.
6 May 2026
Chief Executive Officer
Sold on a plan
23,701
$681.58K
1.5%
MPLT
MapLight Therapeutics, Inc.
5 May 2026
Chief Executive Officer
Sold on a plan
10,472
$295.29K
0.6%
MPLT
MapLight Therapeutics, Inc.
4 May 2026
Chief Executive Officer
Sold on a plan
15,571
$435.36K
1.0%
MPLT
MapLight Therapeutics, Inc.
16 Apr 2026
Chief Executive Officer
Sold at will
10,052
$275.14K
0.6%
MPLT
MapLight Therapeutics, Inc.
15 Apr 2026
Chief Executive Officer
Sold at will
9,135
$246.01K
0.6%
12 decisions on file.
